In response to the historical challenges associated with low treatment effectiveness and extended therapy durations, ToeFX has introduced an innovative solution known as ClearToe Therapy, designed to address the specific needs of patients. Research studies have demonstrated that the ClearToe protocol, which requires approximately 30 minutes per session, can visibly improve the condition of infected toenails within a span of 6 months. Importantly, ClearToe technology has an established track record of safety, with no documented adverse reactions.
Clinical Trial (1-year study):
The eligibility criteria for participation in this study encompassed individuals aged 18 to 75 who were grappling with distal subungual onychomycosis (DSO) and agreed to abstain from using antifungal agents or alternative treatments throughout the study period. DSO represents the most common clinical manifestation, characterized by the separation of the distal nail plate from the nail bed. All patients underwent both clinical assessment and mycological confirmation of fungal presence. Mycological examinations, involving KOH/microscopy, were conducted at Dynacare and LifeLabs Laboratories in Ontario, Canada. Patients received the ToeFX treatment every 2 weeks for a total of 8 sessions, followed by subsequent treatments at 5-week intervals for a period of 6 months. Evaluation of results was performed through digital image analysis and KOH/microscopy.